ClinicalTrials.Veeva

Menu

Digital Therapeutic for Chronic Pain Feasibility Study

University of Washington logo

University of Washington

Status and phase

Completed
Phase 3

Conditions

Chronic Pain

Treatments

Device: 2Morrow Chronic Pain Self-Management Program - digital therapeutic mobile app
Other: Treatment as usual

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06000007
STUDY00016340
1R44AT011593-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The investigators will conduct a 2-arm randomized control feasibility study to evaluate: 1) the feasibility of using the mobile app and an optional activity tracker, 2) the feasibility of conducting a 2-arm trial, and 3) estimate the effect size for planning for a larger efficacy trial based on our primary outcomes. The intervention arm will test a mobile app that aims to help people reduce pain interference who have chronic pain, as well as mental health issues with depression and anxiety. Participants in the intervention arm will also have the option to sense health data with a tracker that integrates with the app, which will inform the feasibility of this feature.

Full description

This study will evaluate the existing 2Morrow Chronic Pain Self-Management Program, in the form of a mobile app, as a digital therapeutic for improving patients' pain self management and function who suffer from chronic pain. Specifically, the investigators will conduct a 2-arm randomized control feasibility study to evaluate: 1) the feasibility of using the mobile app and an optional activity tracker, 2) the feasibility of conducting a 2-arm trial, and 3) estimate the effect size for planning for a larger efficacy trial based on our primary outcomes. The intervention arm will test a mobile app that aims to help people reduce pain interference who have chronic pain, as well as mental health issues with depression and anxiety. Participants in the intervention arm will also have the option to sense health data with a tracker that integrates with the app, which will inform the feasibility of this feature.

Enrollment

108 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • >=18 years old
  • at least one ICD pain related diagnosis noted in the electronic health record (EHR)
  • at least 2 visits in a primary care clinic with at least one in the last 12 months
  • willing to use a mobile app in English
  • T-score for the PROMIS brief pain inventory of >= 55
  • access to a smartphone
  • willing to download and use a mobile app daily

Exclusion criteria

  • current cancer related diagnosis (to exclude cancer related chronic pain)
  • plans for surgery in next 3 months
  • pregnant
  • currently receiving hospice care

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

108 participants in 2 patient groups

Treatment as usual
Active Comparator group
Description:
Treatment as usual arm entails the patients continuing to receive care from their primary care provider and any specialists they choose to get involved in their care.
Treatment:
Other: Treatment as usual
Intervention arm
Active Comparator group
Description:
Intervention arm includes access to the digital therapeutic mobile app in addition to treatment as usual
Treatment:
Device: 2Morrow Chronic Pain Self-Management Program - digital therapeutic mobile app

Trial contacts and locations

1

Loading...

Central trial contact

Brennan Keiser, MSW

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems